Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism PLA2G15 modulators(phospholipase A2 group XV modulators) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization Scenic Biotech BVStartup |
Active Organization Scenic Biotech BVStartup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Frontotemporal Lobar Degeneration | Preclinical | NL | Scenic Biotech BVStartup | 01 Dec 2024 |
Neuronal Ceroid-Lipofuscinoses | Preclinical | NL | Scenic Biotech BVStartup | 01 Dec 2024 |
Niemann-Pick Disease, Type C | Preclinical | NL | Scenic Biotech BVStartup | 09 Jul 2024 |